Lutrate Depot
On the Bulgarian pack: Лутрат Депо 22,5 mg прах и разтворител за инжекционна суспензия с удължено освобождаване
22.5 mg powder and solvent for prolonged-release suspension for injection · powder and solvent for solution for injection
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Leuprorelin
- Made by
- PHARMASCIENCE INTERNATIONAL LIMITED
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Spain3 matching products
- ELIGARD TRIMESTRAL 22,5 mg · polvo y disolvente para solución inyectable en jeringa precargada
- LEUPRORELINA GP-PHARM DEPOT TRIMESTRAL 22.5 mg · polvo y disolvente para suspensión inyectable de liberación prolongada
- LUTRATE DEPOT TRIMESTRAL 22.5 mg · polvo y disolvente para suspensión inyectable de liberación prolongada
CanadaNo exact match for this strength and form
Netherlands7 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | PHARMASCIENCE INTERNATIONAL LIMITED · Cyprus |
|---|---|
| Active substance | Leuprorelin |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 22.5 mg powder and solvent for prolonged-release suspension for injection |
| Form | powder and solvent for solution for injection |
| Pack sizes | 1 |
| Classification | L02AE02 · Cancer treatments and immune-system medicines |
| Name in the register | Лутрат Депо 22,5 mg прах и разтворител за инжекционна суспензия с удължено освобождаване |
| Reg. no. | 20150211 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.